top of page
II-GLP-T

II-GLP-T

$95.00Price
Quantity

Tirzepatide is a novel dual agonist that simultaneously activates GLP‑1 (glucagon‑like peptide‑1) and GIP (glucose‑dependent insulinotropic polypeptide) receptors. This dual mechanism enhances glucose‑dependent insulin secretion while suppressing glucagon release, slowing gastric emptying, and promoting satiety through central appetite regulation. The added GIP activity appears to synergistically amplify metabolic effects beyond GLP‑1 alone, contributing to superior weight reduction observed in clinical trials. Its ~5‑day half‑life enables convenient once‑weekly administration.

 

FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. Royal Nexus is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Royal Nexus is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption.

Gemini_Generated_Image_nxb5h2nxb5h2nxb5_edited.png

Free Shipping over $200, Rapid Customer Support, Same-Day Shipping

Quick Links

Get In Touch

090-788-000

090-788-000

090-788-000

© 2025 Royal Nexus. For Research Use Only. All Rights Reserved.

bottom of page